Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them

Kwang Il Seo, Si Hyun Bae, Pil Soo Sung, Chung-Hwa Park, Hae Lim Lee, Hee Yeon Kim, Hye Ji Kim, Bo Hyun Jang, Jeong Won Jang, Seung Kew Yoon, Jong Young Choi, In-Yang Park, Juyoung Lee, Hyun Seung Lee, Sa-Jin Kim, Jung Hyun Kwon, U Im Chang, Chang Wook Kim, Se Hyun Jo, Young Lee, Fisseha Tekle, Jong-Hyun Kim

Clin Mol Hepatol. 2018;24(4):374-383. Published online June 26, 2018

DOI: https://doi.org/10.3350/cmh.2017.0082

View: 8496 Download: 329 Web of Science: 1

Inactıve hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study

Nese Demirturk, Tuna Demirdal

Clin Mol Hepatol. 2014;20(1):56-60. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.56

View: 8070 Download: 56 Web of Science: 2 Crossref: 1

Review

Chronic hepatitis B in pregnancy: unique challenges and opportunities

Kumaresan Yogeswaran, Scott K. Fung

Clin Mol Hepatol. 2011;17(1):1-8. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.1

View: 7978 Download: 63 Crossref: 16

3

Distribution of hepatitis C virus genotypes determined by line probe assay in Korean patients with chronic HCV infection

Geun Chan Lee, Hyung Gun Kim, Neung Hwa Park, Seon Young Won, Young Hwa Chung, Yung Sang Lee and Dong Jin Suh

Clin Mol Hepatol. 1998;4(3):244-253. Published online January 1, 2000

View: 2434 Download: 20

1 |

Viewed By 5588	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4802	MAFLD: How is it different from NAFLD?
Viewed By 4540	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3711	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3688	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search